WOODCLIFF LAKE, N.J. — Strativa Pharmaceutical, a division of Par Pharmaceutical Cos., announced that the Food and Drug Administration approved Nascobal, a prescription B-12 supplement administered ...
One Spray per Device, Without the Need for Priming, Provides Greater Ease of Use The new Nascobal ® Nasal Spray single-use device requires no assembly and simplifies the tracking of dose ...
Nastech Pharmaceutical Co. Inc. reacquired U.S. rights to Nascobal gel product for vitamin B12 deficiency from Schwarz Pharma AG. Nastech, of Bothell, Wash., will pay Schwartz $8.75 million, plus ...
SAN FRANCISCO (MarketWatch) -- Nastech Pharmaceutical Co. rose 7 percent Tuesday after the U.S. Food and Drug Administration approved its Nascobal nasal spray. The company said the approval triggers a ...
Feb. 3, 2005 — The U.S. Food and Drug Administration (FDA) has approved a nasal spray formulation of cyanocobalamin for the treatment of vitamin B 12 deficiency; a new indication for orphan drug PTC ...
Lupin has obtained the Food and Drug Administration’s permission for two new generics and the company has launched an additional generic. The FDA approved Bromfenac Ophthalmic Solution, 0.075%, which ...
Strativa announced that the FDA has approved Nascobal (cyanocobalamin) Nasal Spray in a single-use device for the maintenance of normal hematologic status in pernicious anemia patients who are in ...
Par announced the launch of Nascobal (cyanocobalamin) Nasal Spray in a single-use device for the maintenance of normal hematologic status in pernicious anemia patients who are in remission following ...
DUBLIN, Aug. 21, 2019 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO) today announced that it has settled its Hatch-Waxman litigation relating to Nascobal® (Cyanocobalamin) Nasal Spray brought ...
One Spray per Device, Without the Need for Priming, Provides Greater Ease of Use ...
Questcor Pharmaceuticals Inc. and Nastech Pharmaceutical Co. Inc. filed a new drug application requesting approval of Nascobal Nasal Spray for the treatment of vitamin B-12 deficiency. (BioWorld Today ...
DUBLIN, March 5, 2019 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO; TASE) today announced that Endo Pharmaceuticals Inc. initiated patent litigation on March 1, 2019 in the United States District ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results